Table 2.
Total recurrence rates by month and distribution of patients receiving single-dose early intravesical chemotherapy
| 6-month relapse | 9-month relapse | 12-month relapse | 24-month relapse | 5-year relapse | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Yes, n (%) | No, n (%) | Yes, n (%) | No, n (%) | Yes, n (%) | No, n (%) | Yes, n (%) | No, n (%) | Yes, n (%) | No, n (%) | |
| Number of patients (%) | 12 (24) | 39 (76) | 21 (41) | 30 (59) | 30 (59) | 21 (41) | 41 (80) | 10 (20) | 43 (84) | 8 (16) |
| Age | ||||||||||
| Mean±SD | 60.7±11.2 | 56.3±12.4 | 59.9±12.0 | 55.6±12.2 | 57.9±12.7 | 56.7±11.7 | 57.4±11.5 | 57.3±15.7 | 57.1±11.9 | 59.0±14.2 |
| P | 0.290* | 0.228* | 0.716* | 0.984* | 0.984* | |||||
| Gender, n (%) | ||||||||||
| Male/female | 9 (75)/3 (25) | 30 (77)/9 (23) | 16 (76)/5 (24) | 23 (77)/7 (23) | 25 (83)/5 (17) | 14 (67)/7 (33) | 33 (80)/8 (20) | 6 (60)/4 (40) | 34 (79)/9 (21) | 5 (63)/3 (38) |
| P | 0.891** | 0.969** | 0.167** | 0.171** | 0.171** | |||||
| Smoking | ||||||||||
| n (%) | 6 (50) | 25 (64) | 13 (62) | 18 (60) | 19 (6) | 12 (57) | 26 (63) | 5 (50) | 26 (61) | 5 (63) |
| P | 0.382** | 0.891** | 0.656** | 0.436** | 0.436** | |||||
| CT | ||||||||||
| n (%) | 1 (8) | 14 (36) | 2 (10) | 13 (43) | 5 (17) | 10 (48) | 9 (22) | 6 (60) | 9 (21) | 6 (75) |
| P | 0.067** | 0.009** | 0.017** | 0.018** | 0.002** | |||||
*t-test, **Chisquare test. CT: Chemotherapy, SD: Standard deviation